Short-Lived Antibody-Mediated Saliva Immunity against SARS-CoV-2 after Vaccination

Authors:

Abstract
Knowledge about the persistence of salivary immunity after SARS-CoV-2 vaccination is limited, and information on this topic could prove important for vaccine strategy and development. We hypothesized that salivary immunity would wane rapidly after vaccination.
Funding Information
  • Carlsbergfondet (CF20-476 0045)
  • Novo Nordisk Fonden (NFF205A0063505)
  • Novo Nordisk Fonden (NNF20SA0064201)
  • Svend Andersen Fonden (SARF2021)

This publication has 33 references indexed in Scilit: